Takeda Pharmaceuticals Australia Pty Ltd has undertaken to be open and transparent in its interactions with the community in which it operates. As a member of Medicines Australia, we publish the details of reportable payments or transfers of value to healthcare professionals. Reportable payments or transfers of value are:
Takeda Pharmaceuticals Australia Pty Ltd prepares reports for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia’s Privacy legislation. The reports for expenditure prior to 1 October 2016 identify healthcare professionals by name where their consent has been provided. Where consent has not been provided the information is reported in aggregate.
From 1 October 2016, reporting these payments is mandatory – details will be reported because healthcare professionals should reasonably expect that all reportable payments or transfers of value will be disclosed for each healthcare professional, by name.
The report is designed to be read on this website. It is also provided as a downloadable CSV file.
To comply with our privacy obligations, the report may be amended from time to time. The report here contains the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, which must comply with the Australian Privacy Act 1988.
For further information about the details in the report, please go to https://medicinesaustralia.com.au
You can find the previous reports here:
Click here for Nov 2017 - April 2018 PDF
Click here for Nov 2017 - April 2018 CSV
Click here for May 2017 - October 2017 PDF
Click here for May 2017 - October 2017 CSV
Click here for November 2016 - April 2017 PDF
Click here for November 2016 - April 2017 CSV
Click here for May 2016 - October 2016 PDF
Click here for May 2016 - October 2016 CSV
Click here for October 2015 - April 2016 PDF
Click here for October 2015 - April 2016 CSV
All reports will be available for at least three years from the date of publication.